
13 Apr 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/anbogen-therapeutics-to-present-dual-breakthroughs-for-imofinostat-abt-301-at-aacr-2026-addressing-immunotherapy-barriers-in-crc-and-chemo-resistance-in-pancreatic-cancer-302739275.html